| | | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2025 ( Subtotal = -$256,637 ) |
| 2025 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R21CA281135 | Improving Rates of Diagnostic Colonoscopy in Native Americans through a Culturally Sensitive Digital Outreach Intervention | 000 | 1 | NIH | 11/13/2024 | $0 |
| 2025 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R21MH138954 | Social Comparison on Social Media, Depressive Symptoms, and Body Dissatisfaction among Adolescents | 000 | 1 | NIH | 10/25/2024 | $0 |
| 2025 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R21AI175595 | Functional and transcriptome analyses of protein kinases in Candida glabrata antifungal drug resistance | 001 | 2 | NIH | 10/28/2024 | $153,599 |
| 2025 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01DA059480 | Elucidating minority stress influences on tobacco use at the intersection of sexual orientation and rurality | 000 | 1 | NIH | 10/17/2024 | $0 |
| 2025 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R21MD019345 | Ecological momentary assessment of daily minority stressors and cannabis and tobacco co-use among sexual minority young adults | 000 | 1 | NIH | 10/15/2024 | $0 |
| 2025 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R34DA060534 | Developing An Empowerment Theory-Based Smoking Cessation Intervention for Sexual and/or Gender Minority People with Community Partners | 000 | 1 | NIH | 10/24/2024 | $0 |
| 2025 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R34DA060534 | Developing An Empowerment Theory-Based Smoking Cessation Intervention for Sexual and/or Gender Minority People with Community Partners | 000 | 1 | NIH | 10/24/2024 | $0 |
| 2025 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | UG1CA233193 | A Lead Academic Participating Site in Oklahoma for the Design and Conduct of NCTN Clinical Trials | 000 | 6 | NIH | 10/23/2024 | $0 |
| 2025 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R33AG072137 | A New Translational Rat Model for Evaluating Anti-Aging Interventions | 000 | 3 | NIH | 11/12/2024 | $28,423 |
| 2025 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | CE153556 | Community Project Funding/Congressionally Directed Spending - Construction | 01 | 1 | HRSA | 11/14/2024 | $0 |
| 2025 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01AG072295 | Cerebromicrovascular rejuvenation by heterochronic blood exchange | 000 | 2 | NIH | 10/15/2024 | $93,522 |
| 2025 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | T03OH008614 | Great Plains Training for Industrial Hygiene Practice and Research | 01 | 21 | CDC | 11/14/2024 | $0 |
| 2025 | 2023 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R21AG072137 | A New Translational Rat Model for Evaluating Anti-Aging Interventions | 000 | 2 | NIH | 11/12/2024 | -$28,423 |
| 2025 | 2023 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01CA241156 | Growth Factor Signaling in Obesity Associated Breast Cancer | 000 | 5 | NIH | 10/29/2024 | $0 |
| 2025 | 2023 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | UH735353 | Regional Genetics Networks | 05 | 4 | HRSA | 11/12/2024 | $0 |
| 2025 | 2023 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | U1Q33082 | Geriatrics Workforce Enhancement Program | 04 | 5 | HRSA | 10/4/2024 | -$1 |
| 2025 | 2023 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | U1Q33082 | Geriatrics Workforce Enhancement Program | 04 | 5 | HRSA | 10/4/2024 | $0 |
| 2025 | 2023 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | T03OH008614 | Great Plains Training for Industrial Hygiene Practice and Research | 01 | 21 | CDC | 11/14/2024 | $0 |
| 2025 | 2022 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01DK119495 | Mechanisms of tuft cell mediated regulation of the intestinal stem cell niche following injury | 000 | 4 | NIH | 10/16/2024 | $0 |
| 2025 | 2022 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | T03OH008614 | Great Plains Training for Industrial Hygiene Practice and Research | 01 | 21 | CDC | 11/14/2024 | $0 |
| 2025 | 2021 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01AG057424 | TESTING THE ABILITY OF NOVEL ASSAYS OF RESILIENCE TO PREDICT LIFESPAN | 000 | 5 | NIH | 10/11/2024 | -$1,838 |
| 2025 | 2021 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | RF1AG072295 | Cerebromicrovascular rejuvenation by heterochronic blood exchange | 000 | 1 | NIH | 10/15/2024 | -$93,522 |
| 2025 | 2021 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01DK116017 | Cytoprotection and the mechanism of action of a natural product Khellin against ER stress | 000 | 4 | NIH | 10/16/2024 | -$5 |
| 2025 | 2021 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01DK116017 | Cytoprotection and the mechanism of action of a natural product Khellin against ER stress | 001 | 3 | NIH | 10/16/2024 | -$2 |
| 2025 | 2021 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | 90DDUC0028 | UCEDD | 03 | 5 | ACL | 10/23/2024 | -$315,082 |
| 2025 | 2020 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01NS098891 | Using Host Responses to Neurocysticercosis to Develop Novel, Brain-imaging Free Diagnostics: a US-India Partnership | 000 | 5 | NIH | 10/15/2024 | -$1,844 |
| 2025 | 2020 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01NS098891 | Using Host Responses to Neurocysticercosis to Develop Novel, Brain-imaging Free Diagnostics: a US-India Partnership | 000 | 5 | NIH | 10/15/2024 | -$91,463 |
| 2025 | 2020 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | 90DDUC0028 | UCEDD | 03 | 5 | ACL | 10/23/2024 | -$1 |
|
| Issue Date FY: 2024 ( Subtotal = $91,286,035 ) (Continued on the next page) |
| 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01DK122028 | Aryl hydrocarbon receptor-mediated differential gene regulation - Mechanism of stanniocalcin 2 mediated protection against NAFLD | 000 | 7 | NIH | 1/12/2024 | $315,375 |
| 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01AG068283 | Tau-induced astrocyte senescence in Alzheimer's disease | 001 | 3 | NIH | 8/16/2024 | $7,458 |
| 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R35GM151013 | Understanding the molecular mechanisms of cilia formation | 000 | 2 | NIH | 7/16/2024 | $362,500 |
| 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | K99AG088478 | Non-invasive brain stimulation and neurovascular mechanisms of post-stroke cognitive impairment | 000 | 1 | NIH | 8/1/2024 | $108,105 |
| 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01AG068283 | Tau-induced astrocyte senescence in Alzheimer's disease | 000 | 3 | NIH | 8/9/2024 | $385,055 |
| 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R21MD019345 | Ecological momentary assessment of daily minority stressors and cannabis and tobacco co-use among sexual minority young adults | 000 | 1 | NIH | 9/17/2024 | $216,772 |
| 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01DK128416 | Maternal Obesity and Pediatric NAFLD: Fetal Origins and Long-term outcomes in Non Human Primates | 000 | 4 | NIH | 7/18/2024 | $536,924 |
| 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01EY035282 | Regulators of Photoreceptor Aerobic Glycolysis in Retinal Health and Disease | 000 | 2 | NIH | 7/3/2024 | $429,322 |
| 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01HL169530 | Mechanism of F-18-fluorodeoxyglucarate accrual in myocardial injury | 000 | 1 | NIH | 3/29/2024 | $362,500 |
| 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 801 NE 13th St. | Oklahoma City | OK | 73104-0000 | OKLAHOMA | USA | H1224834 | Ryan White Title IV Women, Infants, Children, Youth and Affected Family Members AIDS Healthcare | 00 | 12 | HRSA | 7/1/2024 | $139,627 |
| 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01EY033841 | Thyroid Hormone Signaling and Cone Photoreceptor Degeneration | 000 | 3 | NIH | 5/10/2024 | $364,637 |
| 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | U19MD020537 | Improving Cancer Outcomes In Native American Communities (ICON) | 000 | 1 | NIH | 9/17/2024 | $3,516,381 |
| 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01AG059718 | The role of hepatocyte necroptosis and inflammation in liver-brain crosstalk in aging | 001 | 6 | NIH | 7/3/2024 | $409,430 |
| 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01GM104251 | RAMP-altered class B GPCR hormone binding and signaling | 001 | 13 | NIH | 8/15/2024 | $5,652 |
| 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01GM104251 | RAMP-altered class B GPCR hormone binding and signaling | 000 | 13 | NIH | 8/14/2024 | $335,914 |
| 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | H7600185 | Ryan White Part C Outpatient EIS Program | 03 | 28 | HRSA | 8/20/2024 | $17,917 |
| 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | H7600185 | Ryan White Part C Outpatient EIS Program | 00 | 28 | HRSA | 11/16/2023 | $212,514 |
| 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | H7600185 | Ryan White Part C Outpatient EIS Program | 02 | 28 | HRSA | 8/6/2024 | $354,190 |
| 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01CA270234 | Molecular Basis of ME2-mediated Tumor Suppression in Pancreatic Cancer | 001 | 3 | NIH | 7/17/2024 | $111,354 |
| 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | H7600185 | Ryan White Part C Outpatient EIS Program | 01 | 28 | HRSA | 1/26/2024 | $283,352 |
|